BOEUF (Bonesupport Holding AB) Cyclically Adjusted FCF per Share: $-0.13 (As of Mar. 2026)


BOEUF Bonesupport Holding AB BOEUF
81 GF Score
Price $21.40
GF Value $40.52
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Bonesupport Holding AB Cyclically Adjusted FCF per Share?

Bonesupport Holding AB BOEUF 81 Cyclically Adjusted FCF per Share is $-0.13 as of Mar. 2026. GuruFocus rates BOEUF with a GF Score™ of 81/100 and a GF Value™ of $40.52 (Significantly Undervalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Bonesupport Holding AB's adjusted free cash flow per share for the three months ended in Mar. 2026 was $0.119. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $-0.13 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-07-05), Bonesupport Holding AB's current stock price is $21.40. Bonesupport Holding AB's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was $-0.13. Bonesupport Holding AB's Cyclically Adjusted Price-to-FCF of today is .


Bonesupport Holding AB  (OTCPK:BOEUF) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Bonesupport Holding AB Cyclically Adjusted FCF per Share Related Terms


Bonesupport Holding AB Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Bonesupport Holding AB's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bonesupport Holding AB Cyclically Adjusted FCF per Share Chart

Bonesupport Holding AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -0.15

Bonesupport Holding AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.19 -0.17 -0.15 -0.13

BOEUF vs ISRG, BDX, MDLN: Cyclically Adjusted FCF per Share Comparison

For the Medical Instruments & Supplies subindustry, Bonesupport Holding AB's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bonesupport Holding AB Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bonesupport Holding AB's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Bonesupport Holding AB's Cyclically Adjusted Price-to-FCF falls into.


BOEUF
81GF Score
Bonesupport Holding AB BOEUF
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bonesupport Holding AB Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bonesupport Holding AB's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.119/133.5600*133.5600
=0.119

Current CPI (Mar. 2026) = 133.5600.

Bonesupport Holding AB Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 -0.028 101.019 -0.037
201609 -0.074 101.138 -0.098
201612 -0.072 102.022 -0.094
201703 -0.078 102.022 -0.102
201706 -0.034 102.752 -0.044
201709 -0.090 103.279 -0.116
201712 -0.061 103.793 -0.078
201803 -0.087 103.962 -0.112
201806 -0.069 104.875 -0.088
201809 -0.121 105.679 -0.153
201812 -0.112 105.912 -0.141
201903 -0.088 105.886 -0.111
201906 -0.090 106.742 -0.113
201909 -0.084 107.214 -0.105
201912 -0.080 107.766 -0.099
202003 -0.056 106.563 -0.070
202006 -0.060 107.498 -0.075
202009 -0.035 107.635 -0.043
202012 -0.042 108.296 -0.052
202103 -0.026 108.360 -0.032
202106 -0.062 108.928 -0.076
202109 -0.037 110.338 -0.045
202112 -0.032 112.486 -0.038
202203 -0.014 114.825 -0.016
202206 -0.037 118.384 -0.042
202209 -0.015 122.296 -0.016
202212 -0.011 126.365 -0.012
202303 -0.013 127.042 -0.014
202306 -0.056 129.407 -0.058
202309 0.022 130.224 0.023
202312 0.013 131.912 0.013
202403 0.022 132.205 0.022
202406 -0.098 132.716 -0.099
202409 0.061 132.304 0.062
202412 0.098 132.987 0.098
202503 0.068 132.825 0.068
202506 0.075 133.699 0.075
202509 0.112 133.480 0.112
202512 0.085 133.390 0.085
202603 0.119 133.560 0.119

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $-0.13 mean?
Bonesupport Holding AB (BOEUF) has a Cyclically Adjusted FCF per Share of $-0.13 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Bonesupport Holding AB and its competitors.
Is Bonesupport Holding AB's Cyclically Adjusted FCF per Share too high?
Bonesupport Holding AB's current Cyclically Adjusted FCF per Share is $-0.13. Overall, Bonesupport Holding AB has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bonesupport Holding AB's Cyclically Adjusted FCF per Share compare to ISRG and BDX?
Bonesupport Holding AB's Cyclically Adjusted FCF per Share of $-0.13 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Bonesupport Holding AB and its competitors. Bonesupport Holding AB's current Cyclically Adjusted FCF per Share is $-0.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bonesupport Holding AB stock overvalued right now?
Based on GuruFocus' analysis, Bonesupport Holding AB (BOEUF) is currently considered Significantly Undervalued. The stock's GF Value™ is $40.52, compared to a current price of $21.40 — trading 47.2% below its estimated fair value. The current Cyclically Adjusted FCF per Share is $-0.13. Bonesupport Holding AB's overall GF Score™ is 81/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Bonesupport Holding AB (BOEUF), the current Cyclically Adjusted FCF per Share is $-0.13 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bonesupport Holding AB (BOEUF) Overvalued in 2026?

Based on GuruFocus' analysis, Bonesupport Holding AB stock appears to be undervalued. The current stock price of $21.40 is trading 47.2% below its estimated GF Value™ of $40.52. GuruFocus considers Bonesupport Holding AB to be Significantly Undervalued.

Key valuation signals for BOEUF:

  • Cyclically Adjusted FCF per Share: $-0.13
  • GF Value™: $40.52 vs. price of $21.40 (47.2% below fair value)
  • GF Score™: 81/100 with 2 warning signs

No single metric tells the full story. See the BOEUF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bonesupport Holding AB Business Description

Address Scheelevagen 19, Lund, SWE, SE-223 70
Bonesupport Holding AB is a fast-growing ortho-biologics company that focuses on the treatment of bone disorders. The Company develops and commercializes injectable bio-ceramic bone graft substitutes based on its CERAMENT platform, which remodels to bone and can release pharmaceuticals to promote healing. The products of the company focus on trauma, revision arthroplasty (replacement of joint prostheses), chronic osteomyelitis (bone infection), and foot and ankle surgery. The Group manages and monitors operations in two operating segments: United States and Europe & Rest of the World (EUROW).
81GF Score

Get the complete analysis for BOEUF

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$21.40
Price
$40.52
GF Value